Comments Regarding FDA Diversity Action Plans to Improve Enrollment of Participants From Underrepresented Populations in Clinical Studies Share page: Docket Number: FDA–2021–D–0789 Download Document Issues: OTC Medicines Dietary Supplements OTC Medical Devices Other Issues Research Related Posts Press Releases and Statements CHPA Applauds New Mississippi Law to Prevent Unlawful Purchases of PSE-Containing Medicines Mar 21, 2025 OTC Monograph Product Technical Data Outline Advisory Documents
